Also trades as: BIAF (NASDAQ) · $vol 13M
BIAFW NASDAQ
bioAffinity Technologies, Inc.
1W: +14.0%
1M: +106.6%
3M: +111.6%
YTD: +28.7%
1Y: +175.2%
$0.33
+0.01 (+3.28%)
Weekly Expected Move ±72.8%
$-0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$6M
-34.2% ▼
Gross Profit
$1M
-57.7% ▼
Operating Income
-$11M
-18.1% ▼
Net Income
-$15M
-64.9% ▼
EPS (Diluted)
$-8.66
+61.5% ▲
EBITDA
-$10M
-20.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $5K | $3M | $9M | $6M |
| YoY Growth | +0.0% | +0.0% | +52617.1% | +269.7% | -34.2% |
| Cost of Revenue | $5K | $467 | $2M | $6M | $5M |
| Gross Profit | -$5K | $4K | $792K | $3M | $1M |
| Gross Margin | — | 90.3% | 31.3% | 36.1% | 23.2% |
| R&D Expenses | $1M | $2M | $2M | $2M | $2M |
| SG&A Expenses | $876K | $2M | $7M | $10M | $10M |
| Operating Expenses | $2M | $4M | $9M | $12M | $12M |
| Operating Income | -$2M | -$4M | -$8M | -$9M | -$11M |
| Operating Margin | — | -83511.5% | -314.9% | -95.6% | -171.6% |
| Interest Expense | $1M | $3M | $37K | $92K | $44K |
| Income Before Tax | -$6M | -$8M | -$8M | -$9M | -$15M |
| Tax Expense | $2K | $2K | $21K | $12K | $44K |
| Net Income | -$6M | -$8M | -$8M | -$9M | -$15M |
| Net Margin | — | -169771.2% | -313.5% | -96.6% | -242.0% |
| EPS (Diluted) | $-25.80 | $-54.30 | $-27.30 | $-22.50 | $-8.66 |
| EBITDA | -$5M | -$6M | -$8M | -$8M | -$10M |
| Shares Outstanding | 245933 | 149967 | 291600 | 404333 | 2M |